Development of Sensitive Immunoassays for Free and Total Human Glandular Kallikrein 2
Author(s) -
Ville Väisänen,
Susann Eriksson,
Kaisa K. Ivaska,
Hans Lilja,
Martti Nurmi,
Kim Pettersson
Publication year - 2004
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2004.035253
Subject(s) - prostate cancer , prostate specific antigen , antibody , prostate , monoclonal antibody , antigen , detection limit , medicine , andrology , cancer , chemistry , urology , immunology , chromatography
Free and total human kallikrein 2 (hK2) might improve the discrimination between prostate cancer and benign prostatic hyperplasia. Concentrations of hK2 are 100-fold lower than concentrations of prostate-specific antigen (PSA); therefore, an hK2 assay must have a low detection limit and good specificity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom